Firing Roger won't make the patents expire any faster, all that would achieve is removing one of the people who know the molecule best from the team. In my opinion it would slow any progress further. Any replacement would expect to be paid more too, he's not demanding in that regard.
- Forums
- ASX - By Stock
- Phase 3 Canines Lymphoma B Trial ( what to expect)
Firing Roger won't make the patents expire any faster, all that...
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $86.20K | 429.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67508 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 36444 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 67508 | 0.195 |
7 | 258826 | 0.190 |
12 | 723520 | 0.185 |
6 | 377800 | 0.180 |
5 | 151797 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 36444 | 3 |
0.205 | 21529 | 1 |
0.210 | 107676 | 2 |
0.215 | 154400 | 2 |
0.220 | 190000 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online